Reimbursed with a limitationReference productATC M05BX04

Xgeva

Xgeva is a reference product from Amgen Switzerland AG with at least one biosimilar in Switzerland and is listed on the FOPH Specialities List. The public price ranges from CHF 269.30 to CHF 269.30 depending on the pack; the co-payment is 10 per cent.

Core data

Authorisation holder
Amgen Switzerland AG
ATC code
M05BX04
IT group
07.16.10 Cytostatica
Active substances
Denosumabum
Preparation type
Reference product
On the SL since
01/03/2012
Last price change
01/04/2026
Co-payment
10%

Prices per pack

The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.

Xgeva Price table As of 17/09/2026
Dosage formPack sizeEx-factory pricePublic priceValid fromCat.GTIN
Inj Lös 120 mg/1.7 ml Durchstf1.7 mlCHF 229.39CHF 269.3001/03/2012A7680618650014
Inj Lös 120 mg/1 ml Fertspr1 mlCHF 229.39CHF 269.3001/01/2025A7680695200010

Limitation

This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.

The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.

FOPH wordingValid from 01/03/2024

Vergütung bei Patienten mit Knochenmetastasen solider Tumoren in Verbindung mit einer antineoplastischen Standardtherapie.
Vergütung bei Erwachsenen und Jugendlichen mit abgeschlossener Skelettreifung mit Riesenzelltumoren des Knochens, die entweder nicht resezierbar sind oder bei denen eine Resektion wahrscheinlich zu hoher Morbidität führen würde.

More preparations in this group

FAQ

Is Xgeva covered by Swiss health insurance?

Yes, but only under conditions. Xgeva is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.

What does Xgeva cost in Switzerland?

The public price is the maximum price set by the FOPH and for Xgeva ranges from CHF 269.30 to CHF 269.30 per pack. The ex-factory price ranges from CHF 229.39 to CHF 229.39. Pharmacies may not charge more, but may charge less.

Correct or complete this entry

Market access

Do you need your product on the Specialities List?

Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.

  • Independent directory
  • Official FOPH data
  • Website in eight languages
Send an enquiry
Contact

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissreimbursement.com